Research and Markets: Pertussis Therapeutics Pipeline Insights 2015
29 July 2015 - 4:54PM
Business Wire
Research and Markets
(http://www.researchandmarkets.com/research/kksz86/pertussispipeline)
has announced the addition of the "Pertussis-Pipeline Insights"
report to their offering.
Pertussis - Pipeline Insights provides the in-depth analysis of
the pipeline assets across the Pertussis. The main objective of
this report to track competitor pipeline molecules, related
research activities, technology, collaborations, in-licensing and
out-licensing deals. The Pertussis Report helps to identify
emerging players with potentially strong product information and
create effective counter-strategies to gain competitive
advantage.
Pertussis - Pipeline Insights Report covers the Pertussis
pipeline molecules at various stages of development like
Pre-registration phase, clinical phases (Phase III, Phase II &
Phase I), pre-clinical and discovery phases. The Report also
provides Pertussis related therapeutic assessments by molecule
type, route of administration, monotherapy and combination
products. The Report also highlights the discontinued and inactive
projects in pipeline for Pertussis.
Scope
- The report provides a Pertussis Landscape across the globe
- The report provides drug profiles which includes product
description, MOA, licensors & collaborators, technology,
development partner and chemical information
- Coverage of the Pertussis pipeline on the basis of target,
MOA, route of administration, technology involved and molecule
type
- The report reviews key players involved in the therapeutics
development for Pertussis and also provide company profiling
- Pipeline products coverage based on various stages of
development from NDA filings to discovery.
- Provides pipeline assessment by monotherapy and combination
therapy products, stage of development and molecule type
For more information visit
http://www.researchandmarkets.com/research/kksz86/pertussispipeline
View source
version on businesswire.com: http://www.businesswire.com/news/home/20150729006254/en/
Research and MarketsLaura Wood, Senior
Managerpress@researchandmarkets.comFor E.S.T Office Hours Call
1-917-300-0470For U.S./CAN Toll Free Call 1-800-526-8630For GMT
Office Hours Call +353-1-416-8900U.S. Fax: 646-607-1907Fax (outside
U.S.): +353-1-481-1716Sector: Pharmaceuticals